文献速递胃肠外科围术期管理与 ERAS

结肠封堵装置辅助直肠灌洗的随机临床试验

Randomized clinical trial on the use of a colon-occlusion device to assist rectal washout.
PubMed 文献 · Surg Endosc · 2020-09-23

结果显示Coloshield应用可行且安全,灌洗后30分钟BBPS评分在使用组略高(2.42±1.02 vs 2.12±0.89,p=0.042),但灌洗后即刻BBPS无差异,疼痛、排便功能及失禁评分均无显著差异。

要点

  • Coloshield在人体中应用可行且安全,无相关并发症。
  • 使用Coloshield灌洗后30分钟BBPS略优,但即刻评分无差异。
  • 术后疼痛、排便困难及失禁评分两组无显著差异。

核心结论

  • Coloshield人体应用可行且安全,灌洗后30分钟BBPS有轻微优势。

主要发现

  • 灌洗后30分钟BBPS均值:使用组2.42±1.02,未使用组2.12±0.89(p=0.042)。
  • 灌洗后即刻BBPS均值:使用组2.39±1.02,未使用组2.24±0.66(p=0.269)。
  • 术后4小时疼痛NRS中位数:使用组1(0-1),未使用组3(0-4)(p=0.212)。
  • 术后6周排便困难:使用组0/11,未使用组1/11(p=1.0);Vaizey-Wexner评分中位数分别为1(0-3)和1(0-2)(p=0.360)。

临床怎么用

  • Coloshield可安全用于辅助直肠灌洗,对肠道准备有轻微改善,但需进一步临床研究评估其在经直肠NOTES中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transrectal Natural Orifice Transluminal Endoscopic Surgery is currently limited by the inherent risk of surgical site infection due to peritoneal contamination after rectotomy. Coloshield has been developed as a temporary colon occlusion device to facilitate rectal washout. However, effectiveness and safety has not been evaluated in humans. METHODS: Twenty-two patients have been randomly assigned to undergo proctological intervention with a rectal washout with and without the use of Coloshield. Patients and assessors were blinded. Boston Bowel Preparation Scale (BBPS) has been determined 30 min as well as immediately after rectal washout. Feasibility, pain, intra- and postoperative morbidity as well as bowel function and continence 6 weeks after surgery were assessed. RESULTS: BBPS 30 min after rectal washout with and without Coloshield was in mean 2.42 ± 1.02 and 2.12 ± 0.89 (p = 0.042). Mean BBPS immediately after rectal washout was 2.39 ± 1.02 and 2.24 ± 0.66 (p = 0.269). Mean BBPS immediately after rectal washout and 30 min thereafter did not differ (p = 0.711). Coloshield application was feasible without any complications. The median (interquartile range) numeric rating scale for pain 4 h after surgery was 1 (0-1) and 3 (0-4) (p = 0.212). Six weeks after surgery 0/11 and 1/11 patients suffered from evacuation difficulties (p = 1.0) and the median Vaizey-Wexner score was 1 (0-3) and 1 (0-2) (p = 0.360). CONCLUSIONS: Coloshield application in humans is feasible and safe. Slight benefits in rectal preparation by washout are found when Coloshield is used. Colon occlusion by Coloshield for transrectal NOTES should be evaluated within clinical studies. TRIAL REGISTRATION: Clinicaltrials.gov NCT02579330.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Cordewener C, Zürcher M, Müller PC, et al. Randomized clinical trial on the use of a colon-occlusion device to assist rectal washout. Surg Endosc. 2020. PMID: 32968914. doi:10.1007/s00464-020-07992-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。